BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu XR, Liu CQ, Feng BS, Liu ZJ. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol 2014; 20(12): 3255-3264 [PMID: 24695798 DOI: 10.3748/wjg.v20.i12.3255] [Cited by in CrossRef: 114] [Cited by in F6Publishing: 103] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Mu Y, Liu Y, Kishimura A, Mori T, Katayama Y. Effect of Size and Loading of Retinoic Acid in Polyvinyl Butyrate Nanoparticles on Amelioration of Colitis. Polymers (Basel) 2021;13:1472. [PMID: 34063206 DOI: 10.3390/polym13091472] [Reference Citation Analysis]
2 Guzmán M, Keitelman I, Sabbione F, Trevani AS, Giordano MN, Galletti JG. Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease. Clin Exp Immunol 2016;184:248-56. [PMID: 26690299 DOI: 10.1111/cei.12759] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
3 Liao Y, Peng Z, Chen L, Nüssler AK, Liu L, Yang W. Deoxynivalenol, gut microbiota and immunotoxicity: A potential approach? Food and Chemical Toxicology 2018;112:342-54. [DOI: 10.1016/j.fct.2018.01.013] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
4 Kriaa A, Jablaoui A, Rhimi S, Soussou S, Mkaouar H, Mariaule V, Gruba N, Gargouri A, Maguin E, Lesner A, Rhimi M. SP-1, a Serine Protease from the Gut Microbiota, Influences Colitis and Drives Intestinal Dysbiosis in Mice. Cells 2021;10:2658. [PMID: 34685638 DOI: 10.3390/cells10102658] [Reference Citation Analysis]
5 Khan IA, Pilli S, A S, Rampal R, Chauhan SK, Tiwari V, Mouli VP, Kedia S, Nayak B, Das P, Makharia GK, Ahuja V. Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease. PLoS One 2016;11:e0152063. [PMID: 27019109 DOI: 10.1371/journal.pone.0152063] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
6 Michielan A, D’Incà R. Host-microbiome interaction in Crohn’s disease: A familiar or familial issue? World J Gastrointest Pathophysiol 2015; 6(4): 159-168 [PMID: 26600974 DOI: 10.4291/wjgp.v6.i4.159] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
7 Li H, Fan C, Feng C, Wu Y, Lu H, He P, Yang X, Zhu F, Qi Q, Gao Y, Zuo J, Tang W. Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity. Br J Pharmacol 2019;176:2209-26. [PMID: 30883697 DOI: 10.1111/bph.14667] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
8 Fonseca-Camarillo G, Yamamoto-Furusho JK. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:2188-2193. [PMID: 26111210 DOI: 10.1097/mib.0000000000000477] [Cited by in Crossref: 54] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
9 Nunes NS, Kim S, Sundby M, Chandran P, Burks SR, Paz AH, Frank JA. Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis. World J Gastroenterol 2018; 24(38): 4341-4355 [PMID: 30344419 DOI: 10.3748/wjg.v24.i38.4341] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
10 Montoya-Cerrillo D, Bernieh A, Saad AG. Critical diagnoses in paediatric gastrointestinal diseases. Pathology 2022:S0031-3025(21)00540-7. [PMID: 35033374 DOI: 10.1016/j.pathol.2021.09.023] [Reference Citation Analysis]
11 Ilan Y. Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease. Clin Transl Immunology 2016;5:e60. [PMID: 26900473 DOI: 10.1038/cti.2015.47] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
12 Pérez-Brocal V, García-López R, Nos P, Beltrán B, Moret I, Moya A. Metagenomic Analysis of Crohn's Disease Patients Identifies Changes in the Virome and Microbiome Related to Disease Status and Therapy, and Detects Potential Interactions and Biomarkers. Inflamm Bowel Dis 2015;21:2515-32. [PMID: 26313691 DOI: 10.1097/MIB.0000000000000549] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
13 Chen P, Zhu H, Mao Y, Zhuo M, Yu Y, Chen M, Zhao Q, Li L, Wu M, Ye M. SETD8 involved in the progression of inflammatory bowel disease via epigenetically regulating p62 expression. J Gastroenterol Hepatol 2021. [PMID: 33991018 DOI: 10.1111/jgh.15550] [Reference Citation Analysis]
14 Lin ST. Role of fecal calprotectin in evaluation of disease activity and recurrence of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2016; 24(6): 962-966 [DOI: 10.11569/wcjd.v24.i6.962] [Reference Citation Analysis]
15 Fan Y, Yi W, Huang H, Mei Z, Feng Z. Efficacy of herbal medicine (Gegen Qinlian Decoction) on ulcerative colitis: A systematic review of randomized controlled trials. Medicine (Baltimore). 2019;98:e18512. [PMID: 31876740 DOI: 10.1097/md.0000000000018512] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
16 Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol 2017; 23(33): 6137-6146 [PMID: 28970729 DOI: 10.3748/wjg.v23.i33.6137] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 67] [Article Influence: 16.0] [Reference Citation Analysis]
17 Qin L, Yao ZQ, Chang Q, Zhao YL, Liu NN, Zhu XS, Liu QQ, Wang LF, Yang AG, Gao CF, Li JT. Swimming attenuates inflammation, oxidative stress, and apoptosis in a rat model of dextran sulfate sodium-induced chronic colitis. Oncotarget 2017;8:7391-404. [PMID: 28030847 DOI: 10.18632/oncotarget.14080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
18 Dong R, Bai M, Zhao J, Wang D, Ning X, Sun S. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy. Front Cell Infect Microbiol 2020;10:557368. [PMID: 33194798 DOI: 10.3389/fcimb.2020.557368] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Cavalcanti E, Armentano R, Lolli I. Crohn's Disease Following Rituximab Treatment for Follicular Lymphoma in a Patient with Synchronous Gastric Signet Ring Cells Carcinoma: A Case Report and Literature Review. Cancer Res Treat 2020;52:1291-5. [PMID: 32683839 DOI: 10.4143/crt.2020.406] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Zhang J, Zhao Y, Hou T, Zeng H, Kalambhe D, Wang B, Shen X, Huang Y. Macrophage-based nanotherapeutic strategies in ulcerative colitis. Journal of Controlled Release 2020;320:363-80. [DOI: 10.1016/j.jconrel.2020.01.047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
21 Luo A, Leach ST, Barres R, Hesson LB, Grimm MC, Simar D. The Microbiota and Epigenetic Regulation of T Helper 17/Regulatory T Cells: In Search of a Balanced Immune System. Front Immunol 2017;8:417. [PMID: 28443096 DOI: 10.3389/fimmu.2017.00417] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis]
22 Machtaler S, Knieling F, Luong R, Tian L, Willmann JK. Assessment of Inflammation in an Acute on Chronic Model of Inflammatory Bowel Disease with Ultrasound Molecular Imaging. Theranostics. 2015;5:1175-1186. [PMID: 26379784 DOI: 10.7150/thno.13048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
23 Zang KH, Rao Z, Zhang GQ, Qin HY. Anticolitis activity of Chinese herbal formula yupingfeng powder via regulating colonic enterochromaffin cells and serotonin. Indian J Pharmacol 2015;47:632-7. [PMID: 26729955 DOI: 10.4103/0253-7613.169584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
24 Chakravarti D, Lee R, Multani AS, Santoni A, Keith Z, Hsu WH, Chang K, Reyes L, Rashid A, Wu CJ, Li J, Zhang J, Shim HS, Chandra K, Deng P, Spring DJ, Nielsen OH, Riis LB, Mayigegowda KK, Blutt SE, Zhang J, Younes M, DuPont A, Thirumurthi S, Vilar E, Estes MK, Colla S, Shroyer NF, DePinho RA. Telomere dysfunction instigates inflammation in inflammatory bowel disease. Proc Natl Acad Sci U S A 2021;118:e2024853118. [PMID: 34253611 DOI: 10.1073/pnas.2024853118] [Reference Citation Analysis]
25 Chang YC, Ching YH, Chiu CC, Liu JY, Hung SW, Huang WC, Huang YT, Chuang HL. TLR2 and interleukin-10 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice. PLoS One 2017;12:e0180025. [PMID: 28683149 DOI: 10.1371/journal.pone.0180025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
26 Anka Idrissi D, Senhaji N, Aouiss A, Khalki L, Tijani Y, Zaid N, Marhoume FZ, Naya A, Oudghiri M, Kabine M, Zaid Y. IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn's disease and new therapeutic targets. Arch Pharm Res 2021;44:117-32. [PMID: 33394309 DOI: 10.1007/s12272-020-01296-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Ahmad R, Ajlan AM, Eskander AA, Alhazmi TA, Khashoggi K, Wazzan MA, Abduljabbar AH. Magnetic resonance imaging in the management of Crohn's disease: a systematic review and meta-analysis. Insights Imaging 2021;12:118. [PMID: 34406519 DOI: 10.1186/s13244-021-01064-9] [Reference Citation Analysis]
28 Habib I, Mazulis A, Roginsky G, Ehrenpreis ED. Nonsteroidal Anti-inflammatory Drugs and Inflammatory Bowel Disease: Pathophysiology and Clinical Associations. Inflammatory Bowel Diseases 2014;20:2493-502. [DOI: 10.1097/mib.0000000000000165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
29 Rebouças PC, Netinho JG, Cunrath GS, Ronchi LS, de Melo MMC, Gonçalves Filho FDA, Muniz RCC, Martins ATS, de Oliveira RA, Costa Junior RM. Hypovitaminosis D in patients with Crohn's disease. Journal of Coloproctology 2021;36:059-63. [DOI: 10.1016/j.jcol.2016.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
30 Singh G, Brien S, Taylor E. A double conundrum: concurrent presentation of Hashimoto's thyroiditis and ulcerative colitis. BMJ Case Rep 2016;2016:bcr2016215185. [PMID: 27107058 DOI: 10.1136/bcr-2016-215185] [Reference Citation Analysis]
31 Jung HJ, Kang JH, Pak S, Lee K, Seong JK, Oh SH. Detrimental Role of Nerve Injury-Induced Protein 1 in Myeloid Cells under Intestinal Inflammatory Conditions. Int J Mol Sci 2020;21:E614. [PMID: 31963519 DOI: 10.3390/ijms21020614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Chaudhary CL, Gurung P, Jang S, Banskota S, Nam TG, Kim JA, Jeong BS. Synthesis, activity and mechanism of alkoxy-, carbamato-, sulfonamido-, thioureido-, and ureido-derivatives of 2,4,5-trimethylpyridin-3-ol against inflammatory bowel disease. J Enzyme Inhib Med Chem 2020;35:1-20. [PMID: 31619080 DOI: 10.1080/14756366.2019.1677637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Cagliani J, Grande D, Molmenti EP, Miller EJ, Rilo HLR. Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications. J Stem Cell Regen Biol 2017;3. [PMID: 29104965 DOI: 10.15436/2471-0598.17.022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
34 Kageyama T, Matsuo T, Kurakake R, Sano T. Relationship between T cells and microbiota in health and disease. Prog Mol Biol Transl Sci 2020;171:95-129. [PMID: 32475529 DOI: 10.1016/bs.pmbts.2020.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 van Egmond M, Vidarsson G, Bakema JE. Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity. Immunol Rev 2015;268:311-27. [PMID: 26497530 DOI: 10.1111/imr.12333] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
36 Ardizzoni A, Sala A, Colombari B, Giva LB, Cermelli C, Peppoloni S, Vecchiarelli A, Roselletti E, Blasi E, Wheeler RT, Pericolini E. Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis. J Fungi (Basel) 2020;6:E225. [PMID: 33081210 DOI: 10.3390/jof6040225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Li P, Shi J, Zhang P, Wang K, Li J, Liu H, Zhou Y, Xu X, Hao J, Sun X, Pang X, Li Y, Wu H, Chen X, Ge Q. Simulated microgravity disrupts intestinal homeostasis and increases colitis susceptibility. FASEB J 2015;29:3263-73. [PMID: 25877215 DOI: 10.1096/fj.15-271700] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
38 Walker MY, Pratap S, Southerland JH, Farmer-Dixon CM, Lakshmyya K, Gangula PR. Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide 2018;73:81-8. [PMID: 28602746 DOI: 10.1016/j.niox.2017.06.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
39 Oh SJ, Seo Y, Ahn JS, Shin YY, Yang JW, Kim HK, Han J, Mishchenko NP, Fedoreyev SA, Stonik VA, Kim HS. Echinochrome A Reduces Colitis in Mice and Induces In Vitro Generation of Regulatory Immune Cells. Mar Drugs 2019;17:E622. [PMID: 31683521 DOI: 10.3390/md17110622] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
40 Latorre E, Layunta E, Grasa L, Pardo J, García S, Alcalde AI, Mesonero JE. Toll-like receptors 2 and 4 modulate intestinal IL-10 differently in ileum and colon. United European Gastroenterol J 2018;6:446-53. [PMID: 29774159 DOI: 10.1177/2050640617727180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
41 Hodges P, Kelly P. Inflammatory bowel disease in Africa: what is the current state of knowledge? Int Health 2020;12:222-30. [PMID: 32133502 DOI: 10.1093/inthealth/ihaa005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Rana T. Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac017. [PMID: 35312776 DOI: 10.1093/ibd/izac017] [Reference Citation Analysis]
43 Andersen-Civil AIS, Arora P, Williams AR. Regulation of Enteric Infection and Immunity by Dietary Proanthocyanidins. Front Immunol 2021;12:637603. [PMID: 33717185 DOI: 10.3389/fimmu.2021.637603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Bui TM, Mascarenhas LA, Sumagin R. Extracellular vesicles regulate immune responses and cellular function in intestinal inflammation and repair. Tissue Barriers 2018;6:e1431038. [PMID: 29424657 DOI: 10.1080/21688370.2018.1431038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
45 Ma YH, Zhang J, Chen X, Xie YF, Pang YH, Liu XJ. Increased CD4+CD45RA-FoxP3low cells alter the balance between Treg and Th17 cells in colitis mice. World J Gastroenterol 2016; 22(42): 9356-9367 [PMID: 27895423 DOI: 10.3748/wjg.v22.i42.9356] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
46 Titz B, Gadaleta RM, Lo Sasso G, Elamin A, Ekroos K, Ivanov NV, Peitsch MC, Hoeng J. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.Int J Mol Sci. 2018;19. [PMID: 30223557 DOI: 10.3390/ijms19092775] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
47 Raychaudhuri SP, Raychaudhuri SK. Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Res Ther 2017;19:51. [PMID: 28270233 DOI: 10.1186/s13075-017-1249-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
48 Sun X, Huang Y, Zhang YL, Qiao D, Dai YC. Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells. World J Gastroenterol 2020; 26(48): 7593-7602 [PMID: 33505138 DOI: 10.3748/wjg.v26.i48.7593] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 El-Mahdy NA, Saleh DA, Amer MS, Abu-Risha SE. Role of allopurinol and febuxostat in the amelioration of dextran-induced colitis in rats. Eur J Pharm Sci 2020;141:105116. [PMID: 31654756 DOI: 10.1016/j.ejps.2019.105116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
50 Cardoso A, Gil Castro A, Martins AC, Carriche GM, Murigneux V, Castro I, Cumano A, Vieira P, Saraiva M. The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis. Front Immunol 2018;9:400. [PMID: 29545807 DOI: 10.3389/fimmu.2018.00400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
51 Gil-Borras R, García-Ballesteros C, Benet-Campos C, Catalán-Serra I, López-Chuliá F, Cuéllar C, Andreu-Ballester JC. B1a Lymphocytes (CD19+CD5+) Deficiency in Patients with Crohn's Disease and Its Relation with Disease Severity. Dig Dis 2018;36:194-201. [PMID: 29421816 DOI: 10.1159/000486893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
52 Elshazly SM, Elhassanny AEM, Mahmoud NM. Cilostazol protects against acetic acid-induced colitis in rats: Possible role for cAMP/SIRT1 pathway. Eur J Pharmacol 2020;881:173234. [PMID: 32497625 DOI: 10.1016/j.ejphar.2020.173234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Alzahrani J, Hussain T, Simar D, Palchaudhuri R, Abdel-Mohsen M, Crowe SM, Mbogo GW, Palmer CS. Inflammatory and immunometabolic consequences of gut dysfunction in HIV: Parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities. EBioMedicine 2019;46:522-31. [PMID: 31327693 DOI: 10.1016/j.ebiom.2019.07.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
54 Chan SN, Low END, Raja Ali RA, Mokhtar NM. Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence. Intest Res 2018;16:374-83. [PMID: 30090036 DOI: 10.5217/ir.2018.16.3.374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
55 Palacios Argueta P, Salazar M, Attar B, Simons-Linares R, Shen B. 90-Day Specific Readmission for Clostridium difficile Infection After Hospitalization With an Inflammatory Bowel Disease Flare: Outcomes and Risk Factors. Inflamm Bowel Dis 2021;27:530-7. [PMID: 32812037 DOI: 10.1093/ibd/izaa224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Zhang S, Miller DD, Li W. Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System. Int J Mol Sci 2021;22:2128. [PMID: 33669918 DOI: 10.3390/ijms22042128] [Reference Citation Analysis]
57 Ho TH, Cohen BL, Colombel J, Mehandru S. Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy. Aliment Pharmacol Ther 2014;40:1171-86. [DOI: 10.1111/apt.12976] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
58 Sebastián VP, Salazar GA, Coronado-Arrázola I, Schultz BM, Vallejos OP, Berkowitz L, Álvarez-Lobos MM, Riedel CA, Kalergis AM, Bueno SM. Heme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and Progression. Front Immunol 2018;9:1956. [PMID: 30258436 DOI: 10.3389/fimmu.2018.01956] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
59 Antonioli L, Giron MC, Colucci R, Pellegrini C, Sacco D, Caputi V, Orso G, Tuccori M, Scarpignato C, Blandizzi C, Fornai M. Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats. PLoS One. 2014;9:e116253. [PMID: 25549098 DOI: 10.1371/journal.pone.0116253] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
60 Silva MC, Sales-Campos H, Oliveira CJF, Silva TL, França FBF, Oliveira F, Mineo TWP, Mineo JR. Treatment with a Zinc Metalloprotease Purified from Bothrops moojeni Snake Venom (BmooMP-Alpha-I) Reduces the Inflammation in an Experimental Model of Dextran Sulfate Sodium-Induced Colitis. Mediators Inflamm 2019;2019:5195134. [PMID: 31467484 DOI: 10.1155/2019/5195134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Wengrower D, Koslowsky B, Peleg U, Mazuz B, Cohen L, Ben-David A, Gross M, Goldin E, Shaul C. Hearing Loss in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2016;61:2027-32. [PMID: 27048450 DOI: 10.1007/s10620-016-4074-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
62 Lee KK, Jharap B, Maser EA, Colombel JF. Impact of Concomitant Endometriosis on Phenotype and Natural History of Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:159-63. [PMID: 26332310 DOI: 10.1097/MIB.0000000000000577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
63 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
64 Mukherjee S, Joardar N, Sengupta S, Sinha Babu SP. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. J Nutr Biochem 2018;61:111-28. [PMID: 30196243 DOI: 10.1016/j.jnutbio.2018.07.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
65 Qiu H, Sun X, Sun M, He C, Li Z, Liu Z. Serum bacterial toxins are related to the progression of inflammatory bowel disease. Scand J Gastroenterol 2014;49:826-33. [PMID: 24853095 DOI: 10.3109/00365521.2014.919018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
66 Veloso PM, Machado R, Nobre C. Mesalazine and inflammatory bowel disease - From well-established therapies to progress beyond the state of the art. Eur J Pharm Biopharm 2021;167:89-103. [PMID: 34329709 DOI: 10.1016/j.ejpb.2021.07.014] [Reference Citation Analysis]
67 Lu D, Lan B, Din Z, Chen H, Chen G. A vitamin D receptor agonist converts CD4+ T cells to Foxp3+ regulatory T cells in patients with ulcerative colitis. Oncotarget 2017;8:53552-62. [PMID: 28881831 DOI: 10.18632/oncotarget.18614] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
68 Chami B, San Gabriel PT, Kum-Jew S, Wang X, Dickerhof N, Dennis JM, Witting PK. The nitroxide 4-methoxy-tempo inhibits the pathogenesis of dextran sodium sulfate-stimulated experimental colitis. Redox Biol 2020;28:101333. [PMID: 31593888 DOI: 10.1016/j.redox.2019.101333] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
69 Guo Y, Zhou G, He C, Yang W, He Z, Liu Z. Serum Levels of Lipopolysaccharide and 1,3-β-D-Glucan Refer to the Severity in Patients with Crohn's Disease. Mediators Inflamm 2015;2015:843089. [PMID: 26106258 DOI: 10.1155/2015/843089] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
70 Sales-Campos H, de Souza PR, Basso PJ, Ramos AD, Nardini V, Chica JE, Capurro ML, Sá-Nunes A, de Barros Cardoso CR. Aedes aegypti salivary gland extract ameliorates experimental inflammatory bowel disease. Int Immunopharmacol 2015;26:13-22. [PMID: 25770821 DOI: 10.1016/j.intimp.2015.03.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
71 Yu X, Chen X, Sun T. MicroRNA-205-5p Targets HMGB1 to Suppress Inflammatory Responses during Lung Injury after Hip Fracture. Biomed Res Int 2019;2019:7304895. [PMID: 31886244 DOI: 10.1155/2019/7304895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
72 Ardizzoni A, Wheeler RT, Pericolini E. It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset. Front Microbiol 2021;12:692491. [PMID: 34163460 DOI: 10.3389/fmicb.2021.692491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Stras SF, Werner L, Toothaker JM, Olaloye OO, Oldham AL, Mccourt CC, Lee YN, Rechavi E, Shouval DS, Konnikova L. Maturation of the Human Intestinal Immune System Occurs Early in Fetal Development. Developmental Cell 2019;51:357-373.e5. [DOI: 10.1016/j.devcel.2019.09.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
74 Dos Santos Ramos A, Viana GCS, de Macedo Brigido M, Almeida JF. Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets. Pharmacol Res 2021;171:105779. [PMID: 34298111 DOI: 10.1016/j.phrs.2021.105779] [Reference Citation Analysis]
75 Nguyen J, Finkelman BS, Escobar D, Xue Y, Wolniak K, Pezhouh M. Over-expression of Programmed Death Ligand 1 (PD-L1) in Refractory Inflammatory Bowel Disease (IBD). Hum Pathol 2022:S0046-8177(22)00101-0. [PMID: 35489437 DOI: 10.1016/j.humpath.2022.04.011] [Reference Citation Analysis]
76 Juarez JE, Romero T, Mantz CA, Pepin A, Aghdam N, Suy S, Steinberg ML, Levin-Epstein RG, Nickols NG, Kaplan ID, Meier RM, Pham HT, Linson PW, Hong RL, Buyyounouski MK, Bagshaw HP, Fuller DB, Katz AJ, Loblaw A, Collins SP, Kishan AU. Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. Adv Radiat Oncol 2021;6:100759. [PMID: 34585025 DOI: 10.1016/j.adro.2021.100759] [Reference Citation Analysis]
77 Zhang Q, Chen X, Eicher SD, Ajuwon KM, Applegate TJ. Effect of threonine on secretory immune system using a chicken intestinal ex vivo model with lipopolysaccharide challenge. Poult Sci 2017;96:3043-51. [PMID: 28431078 DOI: 10.3382/ps/pex111] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
78 Fábrega MJ, Rodríguez-Nogales A, Garrido-Mesa J, Algieri F, Badía J, Giménez R, Gálvez J, Baldomà L. Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice. Front Microbiol 2017;8:1274. [PMID: 28744268 DOI: 10.3389/fmicb.2017.01274] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
79 Ahluwalia B, Moraes L, Magnusson MK, Öhman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol 2018;53:379-89. [PMID: 29523023 DOI: 10.1080/00365521.2018.1447597] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 14.5] [Reference Citation Analysis]
80 Kmieć Z, Cyman M, Ślebioda TJ. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Adv Med Sci 2017;62:1-16. [PMID: 28126697 DOI: 10.1016/j.advms.2016.09.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 10.6] [Reference Citation Analysis]
81 Dunn ET, Taylor ES, Stebbings S, Schultz M, Butt AG, Kemp RA. Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation. Immunol Cell Biol 2016;94:421-9. [PMID: 26647966 DOI: 10.1038/icb.2015.112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
82 Shimada T, Nagata N, Okahara K, Joya A, Hayashida T, Oka S, Sakurai T, Akiyama J, Uemura N, Gatanaga H. PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection. PLoS One 2017;12:e0184699. [PMID: 28902907 DOI: 10.1371/journal.pone.0184699] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
83 O'Connell L, Winter DC, Aherne CM. The Role of Organoids as a Novel Platform for Modeling of Inflammatory Bowel Disease. Front Pediatr 2021;9:624045. [PMID: 33681101 DOI: 10.3389/fped.2021.624045] [Reference Citation Analysis]
84 Deutschmann C, Sowa M, Murugaiyan J, Roesler U, Röber N, Conrad K, Laass MW, Bogdanos D, Sipeki N, Papp M, Rödiger S, Roggenbuck D, Schierack P. Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease. J Crohns Colitis 2019;13:894-904. [PMID: 30753386 DOI: 10.1093/ecco-jcc/jjz012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
85 Cagol L, Seitel T, Ehrenberg S, Frivolt K, Krahl A, Lainka E, Gerner P, Lenhartz H, Vermehren J, Radke M, Trenkel S, Mayer B, Koletzko S, Debatin K, Mertens T, Posovszky C. Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany. Vaccine 2020;38:1810-7. [DOI: 10.1016/j.vaccine.2019.12.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
86 Bertani L, Antonioli L, Fornai M, Tapete G, Baiano Svizzero G, Marchi S, Blandizzi C, Costa F. Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. Minerva Gastroenterol Dietol 2019;65:298-308. [PMID: 31646851 DOI: 10.23736/S1121-421X.19.02621-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
87 Wilson JC, Furlano RI, Jick SS, Meier CR. Inflammatory Bowel Disease and the Risk of Autoimmune Diseases. J Crohns Colitis. 2016;10:186-193. [PMID: 26507860 DOI: 10.1093/ecco-jcc/jjv193] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
88 Lin R, Piao M, Song Y. Dietary Quercetin Increases Colonic Microbial Diversity and Attenuates Colitis Severity in Citrobacter rodentium-Infected Mice. Front Microbiol 2019;10:1092. [PMID: 31156598 DOI: 10.3389/fmicb.2019.01092] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
89 Poudel S, Napit PR, Briski KP, Mattheolabakis G. Oral Delivery of Nucleic Acids with Passive and Active Targeting to the Intestinal Tissue Using Polymer-Based Nanocarriers. Pharmaceutics 2021;13:1075. [PMID: 34371766 DOI: 10.3390/pharmaceutics13071075] [Reference Citation Analysis]
90 Klotz C, Barret M, Dhooge M, Oudjit A, Chaussade S, Coriat R, Abitbol V. [Management of diagnosis and treatment in ulcerative colitis]. Presse Med 2015;44:144-9. [PMID: 25534469 DOI: 10.1016/j.lpm.2014.06.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
91 Tom MR, Li J, Ueno A, Fort Gasia M, Chan R, Hung DY, Chenoo S, Iacucci M, Jijon HB, Kaplan GG, Beck PL, Panaccione R, Barkema HW, Buret AG, Yajnik V, Ghosh S. Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1596-608. [PMID: 27306067 DOI: 10.1097/MIB.0000000000000848] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
92 Blauvelt A, Chiricozzi A. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis. Clin Rev Allergy Immunol 2018;55:379-90. [PMID: 30109481 DOI: 10.1007/s12016-018-8702-3] [Cited by in Crossref: 149] [Cited by in F6Publishing: 140] [Article Influence: 49.7] [Reference Citation Analysis]
93 Salem M, Lecka J, Pelletier J, Gomes Marconato D, Dumas A, Vallières L, Brochu G, Robaye B, Jobin C, Sévigny J. NTPDase8 protects mice from intestinal inflammation by limiting P2Y6 receptor activation: identification of a new pathway of inflammation for the potential treatment of IBD. Gut 2021:gutjnl-2020-320937. [PMID: 33452178 DOI: 10.1136/gutjnl-2020-320937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
94 Ding S, Jiang H, Fang J. Regulation of Immune Function by Polyphenols. J Immunol Res 2018;2018:1264074. [PMID: 29850614 DOI: 10.1155/2018/1264074] [Cited by in Crossref: 75] [Cited by in F6Publishing: 56] [Article Influence: 18.8] [Reference Citation Analysis]
95 Praveschotinunt P, Duraj-Thatte AM, Gelfat I, Bahl F, Chou DB, Joshi NS. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nat Commun 2019;10:5580. [PMID: 31811125 DOI: 10.1038/s41467-019-13336-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 13.3] [Reference Citation Analysis]
96 Puig L. Psoriasis, artritis psoriásica y enfermedad de Crohn: circuitos de citocinas y papel de la disbiosis. Actas Dermo-Sifiliográficas 2016;107:95-7. [DOI: 10.1016/j.ad.2015.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
97 Moran NR, Webster B, Lee KM, Trotman J, Kwan YL, Napoli J, Leong RW. Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn’s disease. World J Gastroenterol 2015; 21(19): 6072-6076 [PMID: 26019475 DOI: 10.3748/wjg.v21.i19.6072] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
98 Irving PM, de Lusignan S, Tang D, Nijher M, Barrett K. Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study. BMJ Open Gastroenterol 2021;8:e000573. [PMID: 33597152 DOI: 10.1136/bmjgast-2020-000573] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Johnson E, Therkelsen SP, Nentwich I, Nissen-Meyer LSH, Hetland G. IgE-sensitization to food and inhalant allergens in IBD patients compared with normal blood donors at Oslo University Hospital, Norway. Scand J Gastroenterol 2019;54:1107-10. [PMID: 31524013 DOI: 10.1080/00365521.2019.1663445] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. J Transl Med 2019;17:419. [PMID: 31836022 DOI: 10.1186/s12967-019-02174-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
101 Kadiyska T, Tourtourikov I, Popmihaylova AM, Kadian H, Chavoushian A. Role of TNFSF15 in the intestinal inflammatory response. World J Gastrointest Pathophysiol 2018; 9(4): 73-78 [PMID: 30809418 DOI: 10.4291/wjgp.v9.i4.73] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Jones-Hall YL, Nakatsu CH. The Intersection of TNF, IBD and the Microbiome. Gut Microbes. 2016;7:58-62. [PMID: 26939853 DOI: 10.1080/19490976.2015.1121364] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
103 Pritchard GH, Kedl RM, Hunter CA. The evolving role of T-bet in resistance to infection. Nat Rev Immunol 2019;19:398-410. [PMID: 30846856 DOI: 10.1038/s41577-019-0145-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
104 Kwon SH, Seo EB, Lee SH, Cho CH, Kim SJ, Kim SJ, Kim HR, Ye SK. T Cell-Specific Knockout of STAT3 Ameliorates Dextran Sulfate Sodium-Induced Colitis by Reducing the Inflammatory Response. Immune Netw 2018;18:e30. [PMID: 30181918 DOI: 10.4110/in.2018.18.e30] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
105 Wang RX, Zhou M, Ma HL, Qiao YB, Li QS. The Role of Chronic Inflammation in Various Diseases and Anti-inflammatory Therapies Containing Natural Products. ChemMedChem 2021;16:1576-92. [PMID: 33528076 DOI: 10.1002/cmdc.202000996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Besson JCF, de Carvalho Picoli C, Matioli G, Natali MRM. Methyl jasmonate: a phytohormone with potential for the treatment of inflammatory bowel diseases. J Pharm Pharmacol 2018;70:178-90. [PMID: 29072315 DOI: 10.1111/jphp.12839] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
107 Li H, Li Q, Sun S, Lei P, Cai X, Shen G. Integrated Bioinformatics Analysis Identifies ELAVL1 and APP as Candidate Crucial Genes for Crohn's Disease. J Immunol Res 2020;2020:3067273. [PMID: 32724827 DOI: 10.1155/2020/3067273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
108 Suri K, Bubier JA, Wiles MV, Shultz LD, Amiji MM, Hosur V. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models. Cells 2021;10:2204. [PMID: 34571853 DOI: 10.3390/cells10092204] [Reference Citation Analysis]
109 He X, Liu J, Long G, Xia XH, Liu M. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota. Biomed Pharmacother 2021;137:111420. [PMID: 33761623 DOI: 10.1016/j.biopha.2021.111420] [Reference Citation Analysis]
110 Pagliari D, Gambassi G, Piccirillo CA, Cianci R. The Intricate Link among Gut "Immunological Niche," Microbiota, and Xenobiotics in Intestinal Pathology. Mediators Inflamm 2017;2017:8390595. [PMID: 29118468 DOI: 10.1155/2017/8390595] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
111 Soufli I, Toumi R, Rafa H, Touil-Boukoffa C. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016; 7(3): 353-360 [PMID: 27602236 DOI: 10.4292/wjgpt.v7.i3.353] [Cited by in CrossRef: 145] [Cited by in F6Publishing: 124] [Article Influence: 24.2] [Reference Citation Analysis]
112 Jølving LR, Nielsen J, Beck-Nielsen SS, Nielsen RG, Friedman S, Kesmodel US, Nørgård BM. The Association Between Maternal Chronic Inflammatory Bowel Disease and Long-term Health Outcomes in Children-A Nationwide Cohort Study. Inflamm Bowel Dis 2017;23:1440-6. [PMID: 28719543 DOI: 10.1097/MIB.0000000000001146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]